Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Ointment formulation of BioCryst's BCX-34 enters phase II for psoriasis

May 20, 1997

Safety, pharmacological, phase I and early phase II results for SM-10902

May 20, 1997

CytoMed initiates phase II trials of CMI-392

May 9, 1997

Dermik introduces combination acne therapy in South Africa

May 9, 1997

FDA advisory panel denies approval for Genzyme's Sepracoat

May 8, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Positive phase III results from Hyal's actinic keratosis trial

April 28, 1997

Gliatech's ADCON-L to recieve expedited review by FDA

April 24, 1997

LifeCell reports clinical data on AlloDerm

April 23, 1997

Promising data reported from pilot trial of Lubricoat Gel for adhesions

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...